{name}
{subtitle}
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~10 mi. (Törökbálint, Hungary, +122 more cities)
facility
Tudogyogyintezet Torokbalint ( Site 1304)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~10 mi. (Törökbálint, Hungary, +145 more cities)
facility
Tudogyogyintezet Torokbalint ( Site 2302)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)
city
~10 mi. (Törökbálint, Hungary, +28 more cities)
facility
Torokbalint Tudogyogyintezet-Onkopulmonologiai Jarobeteg Centrum ( Site 2801)
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~17 mi. (Budapest, Hungary, +226 more cities)
facility
Országos Onkológiai Intézet-Urogenital Tumors Department and Clinical Pharmacology ( Site 1325)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~37 mi. (Székesfehérvár, Hungary, +201 more cities)
facility
Fejer Megyei Szent Gyorgy Korhaz /ID# 222953
drug
azacitidine, +1 more drug
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~60 mi. (Kecskemét, Hungary, +144 more cities)
facility
Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 2308)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type